NeuroVasc Technologies
- Company typePrivate
- Founded2015
- HeadquartersLaguna Hills, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
NeuroVasc Technologies firmographics
Firmographics- Name
- NeuroVasc Technologies
- Legal name
- NeuroVasc Technologies, Inc.
- Website
- https://neurovasctechnologies.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
NeuroVasc Technologies industry classification
Industry- Product category
- Neurovascular Medical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Thrombectomy, Embolic Protection & Stroke Intervention Devices (HLAHAFAJ)
Keywords
Where NeuroVasc Technologies is headquartered
LocationHeadquarters
- HQ city
- Laguna Hills
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
NeuroVasc Technologies business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Operations, Supply Chain, Personnel, Marketing or Sales, Others
Revenue model
- Neurovascular Medical Device Sales: Sale of neurovascular treatment devices including mechanical thrombectomy systems (eNVi™-SR), micro/intermediate catheters (eNVoke™), and aspiration catheters (eNVac™). Revenue generated through direct commercial activities in cleared markets across 35+ countries. Medical devices sold to hospitals and interventional radiology/neurology departments.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
NeuroVasc Technologies product offering
Product offeringCore offering
NeuroVasc Technologies designs, develops, and manufactures catheter-based neurovascular medical devices for the treatment of ischemic stroke and other neurovascular diseases. Its commercial product portfolio includes the eNVi-SR mechanical thrombectomy stent retriever, the eNVoke family of micro and intermediate catheters, and the eNVac aspiration catheter. Devices are sold directly to hospitals and interventional neuroradiology/neurology departments across more than 35 countries where CE Mark or local regulatory clearance has been obtained.
Product overview
NeuroVasc Technologies develops a portfolio of novel catheter-based technologies for stroke treatment and neurovascular disease intervention. The product portfolio consists of three core device families: the eNVi™-SR mechanical thrombectomy stent retriever for clot removal in ischemic stroke; the eNVoke™ family of micro and intermediate catheters with TipTech™ for device delivery and navigation; and the eNVac™ aspiration catheter with TipTech™ for thrombus aspiration. These catheter-based technologies are designed to work together to provide broad treatment options for patients suffering stroke and other neurovascular diseases.
Differentiator
Problem solved
Functional benefit
Products and services
- eNVi-SR Mechanical Thrombectomy Stent Retriever Next-generation mechanical thrombectomy stent retriever designed for restoring blood flow by removing thrombus in the neurovasculature of ischemic stroke patients. Features articulating segments that remain open under tension through tortuous anatomy to promote clot retention. Available in multiple diameters (3mm-5mm) and working lengths (10mm-55mm), with an extension wire for simplified catheter exchange. CE Mark certified; intended for use by interventional neuroradiologists and neurology specialists in hospitals.
- eNVoke Micro and Intermediate Catheters Micro and intermediate catheters featuring TipTech tip technology for neurovascular and peripheral access. Used for the introduction of interventional devices and infusion of diagnostic or therapeutic agents into neuro, peripheral, and coronary vasculatures. Variable stiffness profiles and PTFE inner liner facilitate stent-retriever thrombectomy and device delivery/re-sheathing. CE Mark certified; intended for interventional neuroradiology and neurology specialists.
- eNVac Aspiration Catheter Variable stiffness, large diameter single lumen aspiration catheter with TipTech tip technology for the introduction of interventional devices and the removal/aspiration of emboli and thrombi from arterial vasculature including peripheral and neuro vasculatures. Features hydrophilic coating and radiopaque marker band for navigation and visibility. CE Mark certified; intended for interventional specialists performing neurovascular and peripheral procedures.
Companies that use NeuroVasc Technologies
Customer profileSegments2 records
Ideal customer profiles1 record
NeuroVasc Technologies technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
NeuroVasc Technologies partnerships and signals
Strategic signalScale indicators4 records
Recent moves7 records
Expansion highlights5 records
NeuroVasc Technologies competitors and assessment
Company assessmentDirect peers
- Penumbra: Penumbra's neurovascular franchise directly competes with NeuroVasc, offering the Indigo aspiration system and RED stent retriever for mechanical thrombectomy—virtually identical products, indications, and target customers in interventional neuroradiology.
- Vesalio: Vesalio develops the NeVa stent retriever and other neurovascular devices for stroke thrombectomy. As a private, venture-backed peer at similar scale and stage, it is closely comparable to NeuroVasc on product, geography, and funding profile.
- Rapid Medical: Rapid Medical develops the Tigertriever adjustable stent retriever and other neurovascular devices. It competes directly with NeuroVasc in mechanical thrombectomy and shares a similar profile as an emerging, innovation-focused private neurovascular company.
- Phenox: Phenox manufactures the pRESET stent retriever and a full family of neurovascular devices, including access catheters. As a European-based neurovascular specialist with CE-marked products, it is a close comparable to NeuroVasc on geography, product mix, and commercial stage.
- Balt (Balt USA): Balt offers a broad portfolio of neurointerventional devices, including stent retrievers and aspiration catheters for stroke treatment. It is a relevant direct peer, particularly in European and international markets where NeuroVasc's CE-marked products compete.
Broad incumbents
- Stryker (Neurovascular): Stryker markets the Trevo ProVue stent retriever and a full neurovascular portfolio (coils, access catheters, flow diverters). As the market leader in stent-retriever thrombectomy, Stryker is the most direct large-incumbent comparable on product and customer overlap.
- Medtronic (Neurovascular): Medtronic's Solitaire stent retriever and React aspiration catheter target the same ischemic stroke thrombectomy workflow. As a global medical device giant, Medtronic brings substantially greater commercial reach and a broader hospital relationship footprint than NeuroVasc.
- Johnson & Johnson (Cerenovus): Cerenovus offers the Embotrap stent retriever and a full stroke portfolio, competing head-to-head with NeuroVasc in the same hospitals. Its parent J&J provides significant R&D and commercial resources against which a private neurovascular startup must compete.
- MicroVention (Terumo): MicroVention, a Terumo subsidiary, sells stent retrievers, access catheters, and flow diversion devices for neurovascular intervention. Its portfolio breadth and Terumo's global manufacturing scale make it a relevant large-incumbent comparator in the same procedural category.
Emerging players
- Anaconda Biomed: Anaconda Biomed is developing next-generation stent retriever and aspiration catheter systems for ischemic stroke. It overlaps with NeuroVasc on catheter-based thrombectomy technology and serves a similar early-stage, clinical-trial-driven profile.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
NeuroVasc Technologies social profiles
Digital presenceNeuroVasc Technologies compliance and trust
Trust signalCompliance4 records
NeuroVasc Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
NeuroVasc Technologies leadership team
Management profileNumber of profiles
Profiles1 record
NeuroVasc Technologies funding detail
Funding detailFunding overview
Funding rounds4 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NeuroVasc Technologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NeuroVasc Technologies
What does NeuroVasc Technologies do?
NeuroVasc Technologies designs, develops, and manufactures catheter-based neurovascular medical devices for the treatment of ischemic stroke and other neurovascular diseases. Its commercial product portfolio includes the eNVi-SR mechanical thrombectomy stent retriever, the eNVoke family of micro and intermediate catheters, and the eNVac aspiration catheter. Devices are sold directly to hospitals and interventional neuroradiology/neurology departments across more than 35 countries where CE Mark or local regulatory clearance has been obtained.
Is NeuroVasc Technologies a public or private company?
NeuroVasc Technologies is a private company. It is classified as venture growth investor backed and is currently operating.
When was NeuroVasc Technologies founded?
NeuroVasc Technologies was founded in 2015. It employs 11 to 50 people.
Where is NeuroVasc Technologies based?
NeuroVasc Technologies is headquartered in Laguna Hills, United States, in the North America region.
How does NeuroVasc Technologies make money?
One revenue line is on record: neurovascular Medical Device Sales.
Who are NeuroVasc Technologies's main competitors?
Direct peers on record are Penumbra, Vesalio, Rapid Medical, Phenox and Balt (Balt USA). Broad incumbents are Stryker (Neurovascular), Medtronic (Neurovascular), Johnson & Johnson (Cerenovus) and MicroVention (Terumo). Anaconda Biomed is listed as an emerging player.
Does NeuroVasc Technologies have an API?
No public API is recorded for NeuroVasc Technologies.
What industry is NeuroVasc Technologies in?
NeuroVasc Technologies's product category is Neurovascular Medical Devices. Its primary akta.pro industry code is HLAHAFAJ, Thrombectomy, Embolic Protection & Stroke Intervention Devices. Its NAICS code is 339112 and its SIC code is 3841.